{"id":"W3092086455","doi":"10.1016/j.urology.2020.09.040","title":"Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study","year":2020,"lang":"en","type":"article","venue":"Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Astellas Pharma Global Development","keywords":"Medicine; Tamsulosin; Mirabegron; Overactive bladder; Lower urinary tract symptoms; Placebo; Adverse effect; Urology; Discontinuation; Internal medicine; Anesthesia; Hyperplasia; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001089661,0.0003218169,0.001235557,0.000224957,0.0002015893,0.00004352669,0.0001975911,0.0001227083,0.0003505766],"category_scores_gemma":[0.0004762644,0.0001914835,0.0002019162,0.0007751997,0.0001834291,0.0001048914,0.00005318926,0.0006602908,0.00001144651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001224184,"about_ca_system_score_gemma":0.0002667789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004720712,"about_ca_topic_score_gemma":0.0003886709,"domain_scores_codex":[0.9964959,0.001336254,0.0004971872,0.0007187316,0.0004243389,0.0005275739],"domain_scores_gemma":[0.9933632,0.005808025,0.0001639419,0.0003883219,0.0001081685,0.0001683488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9429707,0.001259316,0.01142965,0.00002167357,0.007043284,0.0002250464,0.02922711,0.002227899,0.0004018245,0.00004294669,0.000334379,0.0048162],"study_design_scores_gemma":[0.8266477,0.03629969,0.01401357,0.0000403961,0.003732212,0.00003220463,0.00986198,0.1073315,0.0001991054,0.0002494746,0.00116263,0.0004294881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741477,0.0004678857,0.003329206,0.01174634,0.00003097257,0.008975495,0.0001296421,0.00005387394,0.001118931],"genre_scores_gemma":[0.9962291,0.0001544681,0.0001447338,0.002051698,0.00009693905,0.0009478902,0.0002164773,0.00005109033,0.0001076242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.116323,"threshold_uncertainty_score":0.7808469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04598839020554125,"score_gpt":0.348566006494099,"score_spread":0.3025776162885577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}